Opendata, web and dolomites

CARDIACSENSE SIGNED

A new clinically proven and reliable medical solution for continuous heart arrhythmia and blood pressure monitoring

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 CARDIACSENSE project word cloud

Explore the words cloud of the CARDIACSENSE project. It provides you a very rough idea of what is the project "CARDIACSENSE" about.

cardiacsense    sharing    sensitive    monitoring    free    grade    mainly    obtrusive    measuring    health    launch    watch    jobs    medical    boost    800m    hypertension    ltd    sense    continuous    revenues    ppg    arrhythmia    accuracy    israeli    error    mostly    invasive    positive    clinically    inflating    proven    introducing    bp    20    half    finalize    trl6    delivers    encountered    sensor    training    vision    start    false    risk    pulse    blood    detects    storage    365    first    wearable    precise    healthcare    signs    small    500    individuals    connectivity    500bn    adults    atrial    globally    cardiac    surgery    unaware    2009    fibrillation    signal    wrist    market    ischaemic    htn    save    5m    reliably    af    company    2025    besides    time    yearly    data    lives    heart    risks    vital    artefact    suffering    device    stroke    optical    monitor    patients    solution    finger    costing    movements    pressure    lack    23    consists    innovative   

Project "CARDIACSENSE" data sheet

The following table provides information about the project.

Coordinator
CARDIACSENSE 

Organization address
address: 4 LESHEM ST
city: CAESARA
postcode: 3079825
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Israel [IL]
 Project website https://www.cardiacsense.com
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2018
 Duration (year-month-day) from 2018-12-01   to  2019-03-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    CARDIACSENSE IL (CAESARA) coordinator 50˙000.00

Map

 Project objective

Atrial fibrillation (AF) is the most common heart arrhythmia in adults and a major risk factor for ischaemic stroke (increased by 500%), costing globally around €500Bn/year. On the other hand, Hypertension (HTN) is a condition, mostly encountered in patients suffering from AF, although only half of these individuals have this condition under control, and only 20% are unaware that they have HTN. Besides the health risks associated with these conditions, there is a lack of non-obtrusive, non-inflating, non-invasive, small, precise, easy-to-use devices for continuous monitoring of vital signs, including AF and blood pressure. Cardiac Sense Ltd is an Israeli start-up established in 2009, with a vision of developing innovative non-invasive technology for monitoring vital signs. We are developing CardiacSense (TRL6), a clinically-proven medical solution that reliably delivers non-invasive and non-inflating heart arrhythmia and blood pressure monitoring, 23/365 for as long as needed. It mainly consists of a wearable (a watch), highly sensitive, error-free (introducing an artefact sensor), real-time measuring device, that is non-invasive (no surgery needed), easy to use (no training needed) and allows for a great connectivity (providing easy data storage and sharing). Our solution is based on optical PPG sensor technology to monitor heart AF and BP. In addition, we are the first company to develop a unique artefact sensor that detects finger and wrist movements that affect the PPG signal by increasing false positive results. Our solution thus has a medical grade accuracy level of pulse measurement. Through this project we aim to finalize its development and launch it to the market, with a potential to save around €800M to EU healthcare and save up to 5,000 lives yearly, and to boost our company's growth to €7.5M revenues, and 20 new jobs by 2025.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "CARDIACSENSE" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "CARDIACSENSE" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

DetectInMen (2019)

Infection detection in human semen

Read More  

Path Feel (2019)

Insoles for Neuropathy and Balance Issues

Read More  

QTB4AMR (2019)

Utilizing an innovative chemical platform to defeat antimicrobial resistance

Read More